
    
      To determine the efficacy and safety of sequential therapy with Fluocinolone acetonide 0.01%,
      Hydroquinone 4% and Tretinoin 0.05%, and a series of Glycolic Acid peels in the treatment of
      moderate to severe melasma.
    
  